Indwelling pleural catheters for non-malignant pleural effusions: report on a single centre's 10 years of experience.

Efficacy in symptom relief and a generally manageable safety profile recommend IPC as a first-line treatment option in NMPE, where disease-specific treatments are exhausted. Caution is warranted in patients with HH due to an excess risk for complications.